Premium
Taking the kidney to heart
Author(s) -
Ooi Yinn Shaung,
Gray William A.
Publication year - 2020
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.28924
Subject(s) - medicine , impella , risk stratification , conventional pci , percutaneous , contrast induced nephropathy , intensive care medicine , acute kidney injury , cardiology , psychological intervention , nephropathy , kidney , percutaneous coronary intervention , heart failure , ventricular assist device , myocardial infarction , diabetes mellitus , endocrinology , psychiatry
Key Points Growing evidence supports the role of Impella in the prevention of acute kidney injury in high‐risk percutaneous interventions (HR‐PCIs). The Mehran contrast‐induced nephropathy risk score may serve as a helpful risk stratification tool in discerning patients undergoing HR‐PCI who may benefit from renal protection with Impella support. Further research is warranted to validate this renal protection strategy.